U.S. Presidential candidate proposes legislation that would help bring generic versions of biotech drugs to market.
|
JPMorgan's annual healthcare confab. highlights trends and themes shaping the sector.
|
It’s decision time for “hybrid” human-animal embryos.
|
Federal agency plans to deregulate genetically engineered rice.
|
Scientists engineer toxin-free cotton to be used as protein source.
|
Even stagnancy can be sweet.
|
Pharma giant pays hefty premium for biotech firm to get into growing RNAi market.
|
New price caps still leave cancer treatment beyond reach of most.
|
Board asks shareholders to reject Icahn’s proposal.
|
Bad news for cat herd-owning shut-ins.
|
Healthcare, IT sectors lead charge, along with renewables.
|
Top stories for the week of June 26, 2006: Fighting Cervical Cancer; Biotech Buying; iPod Ultrasounds
|
As the life sciences industry matures, VCs need to go with the flow.
|
Industry attracts immense interest from European partners.
|
Red Herring magazine's bioscience news briefs for the week of May 1, 2006.
|
Indian, Canadian groups to collaborate on research, commercialization, and personnel.
|
Bioscience news briefs for the week of April 24, 2006.
|
Whether Wyeth’s bid to become more ‘biotech’ works or not, startups will benefit.
|
Biotech sector says there aren’t enough tax incentives in India’s finance budget for the sector to compete globally.
|
Origen Therapeutics, which raises chickens to lay human antibodies, isn't the only firm scouring the barnyard.
|
Page
1
of
2
|